-
Reduce PSA level to less than 4 in inclusion criteria: CDSCO Panel Tells Akum Drugs and Pharmaceuticals on FDC Dutasteride plus Silodosin
18 Apr 2024 23:40 GMT
… of medications called 5-alpha reductase inhibitors. It works by blocking the …
-
Govorestat linked to functional Improvement in sorbitol dehydrogenase deficiency, findsTrial
18 Apr 2024 16:17 GMT
… central nervous system penetrant Aldose Reductase Inhibitor, which blocks the conversion of …
-
Tadalafil versus tamsulosin as combination therapy with 5-alpha reductase inhibitors in benign prostatic hyperplasia, urinary and sexual outcomes.
04 Feb 2024 18:14 GMT
To compare the urological and sexual outcomes of using either tamsulosin/finateride or tadalafil/finasteride as combination therapies in patients with large prostate.
Selection criteria included prostate volume > 40 ml and IPSS > 7. Patients …
-
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
07 Jan 2024 16:21 GMT
… of treatment with a 5α-reductase inhibitor (5ARI), an alpha-adrenergic receptor …
-
The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study.
06 Jan 2024 04:51 GMT
… effects of taking 5-alpha reductase inhibitors (5ARIs) on the development of …
-
Neutral Result With Novel Agent in Diabetic Cardiomyopathy
16 Apr 2024 11:00 GMT
… the ability of an aldose reductase inhibitor to stabilize early-stage asymptomatic … trial was that the aldose reductase inhibitor AT-001 could abort this …
-
Alpha-blockers show worse CV outcomes compared to 5-Alpha Reductase Inhibitors in BPH patients
27 Nov 2023 09:36 GMT
… cardiovascular outcomes compared with 5-α reductase inhibitors.
The study was published in … α-blockers (ABs) versus 5-α reductase inhibitors (5-ARIs).
The analysis encompassed … of α-blockers vs 5-α reductase inhibitors for benign prostatic hyperplasia. JAMA …
-
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
15 Apr 2024 11:00 GMT
… central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of …
-
Topical Versus Oral Minoxidil: Differences in Efficacy for Men with Androgenetic Alopecia
14 Apr 2024 16:12 GMT
… of minoxidil and the 5-α reductase inhibitors in androgenetic alopecia treatment of …
-
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.
05 Oct 2023 07:27 GMT
… if exposure to 5-alpha-reductase inhibitors (5-ARIs) modifies the effect …